Bausch Health
BHC
#3746
Rank
C$3.98 B
Marketcap
$10.79
Share price
-0.13%
Change (1 day)
-1.71%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$3.61

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$3.84. In 2022 the company made an earnings per share (EPS) of -$0.90 an increase over its 2021 EPS that were of -$3.84.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.61301.65%
2022-$0.90-76.64%
2021-$3.8468.45%
2020-$2.28-68.91%
2019-$7.34-57.11%
2018-$17.11-272.22%
2017$9.94-199.29%
2016-$10.01798.7%
2015-$1.11-128.31%
2014$3.93-204.62%
2013-$3.76602.7%
2012-$0.54-171.15%
2011$0.75-143.96%
2010-$1.71-206.57%
2009$1.61-11.2%
2008$1.812.46%
2007$1.76-7.58%
2006$1.91-14.29%
2005$2.2354%
2004$1.45-500%
2003-$0.36-141.67%
2002$0.87-4.76%
2001$0.91-175%
2000-$1.21-268%
1999$0.7214.94%
1998$0.6320.83%
1997$0.5253.83%
1996$0.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.45-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.39-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA